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MORAL NIMBY-ISM?
UNDERSTANDING SOCIETAL SUPPORT
FOR MONETARY COMPENSATION TO
PLASMA DONORS IN CANADA
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I
INTRODUCTION
The legal status and regulation of economic transactions does not depend
only on considerations about their economic efficiency, but also on the societal
support for a particular exchange to occur through a market (if at all). Widely
held concerns that the individuals engaging in certain transactions may be
exploited or unduly influenced; that the terms of trade may not be fair; or that
some transactions violate human dignity, the sanctity of life, or traditional
institutions; may lead a society to prohibit certain trades.1 These principles may
represent sacred values that take priority over material considerations and
contribute to defining common identities or a collective conscience that allows
even complex societies to be tied together.2 Alvin Roth defines as “repugnant”
those transactions that third parties wish to prohibit even if the underlying

Copyright © 2018 by Nicola Lacetera and Mario Macis.
This article is also available online at http://lcp.law.duke.edu/.
∗
Associate Professor of Management, University of Toronto and University of Toronto
Mississauga, Chief Scientist at Behavioural Economics in Action @ Rotman, Research Associate at the
National Bureau of Economic Research, and a Fellow at CESifo, the U of T Centre for Ethics, the
Canadian Centre for Health Economics, and the Bureau of Research on Innovation, Knowledge and
Complexity.
∗∗
Associate Professor of Economics, Johns Hopkins University Carey Business School; Associate
Faculty, Johns Hopkins School of Medicine Armstrong Institute; Faculty research fellow, National
Bureau of Economic Research (NBER), Institute for the Study of Labor (IZA, and Center for NorthSouth Economic Research (CRENoS)). This research was funded in part by the Johns Hopkins
University Catalyst Award.
1. See DEBRA SATZ, WHY SOME THINGS SHOULD NOT BE FOR SALE: THE MORAL LIMITS OF
MARKETS 94–98 (Samuel Freeman ed., 2010) (listing four primary indicators of noxious markets:
extremely harmful outcomes for participants or third parties, extremely harmful outcomes for society,
highly asymmetric knowledge on the part of participants, and extreme vulnerabilities of transacting
parties).
2. See EMILE DURKHEIM, THE DIVISION OF LABOR IN SOCIETY 38–39 (Anthony Giddens ed.,
W.D. Halls trans., 1984) (arguing that society’s shared moral values create a “collective consciousness,”
and acts are considered criminal when they offend this shared consciousness).

LACETERA_MACIS_PAGINATED (DO NOT DELETE)

84

LAW AND CONTEMPORARY PROBLEMS

5/9/2018 12:00 PM

[Vol. 81:83

exchanges may be beneficial for the parties directly involved.3
Examples of transactions that raise or have raised moral concerns often
leading to their prohibition include prostitution, same-sex marriage, indentured
servitude, and markets for human organs for transplantation.4 As one considers
this (incomplete) list of examples, one observation that emerges is that the legal
treatment of several of these transactions has changed over time in many
countries. For instance, same-sex marriage, which until recently was nearly
universally prohibited because it was regarded as in conflict with religious and
traditional values, is now legal in several countries.5 Additionally, countries that
otherwise share many similarities in terms of social structure, level of economic
development, and historical and cultural roots treat certain transactions
differently. For example, prostitution is legal in Germany but illegal in France,
and commercial surrogacy is legal in several jurisdictions in the United States6
but illegal in Canada.7
These legislative choices raise several questions as to whether the different
legal treatments of certain transactions actually reflect different levels of societal
support for those activities across countries, and if so, why. Moreover, seeming
inconsistencies introduce additional challenges to our understanding of what
explains support for, or opposition to, morally contentious transactions. This
article will focus on one such apparent inconsistency: the case of plasma
donations in Canada and the United States. The United States allows payments
for plasma donors and the establishment of for-profit plasma centers. In most
provinces of Canada, in contrast, payments to plasma donors are illegal.
Canadian policy makers justify the ban on compensation on the basis of moral
considerations and on concerns regarding the safety of plasma collected from
paid donors. However, Canada relies on imported plasma from American paid
donors to meet its need for plasma-derived therapies. For example,
approximately 83% of immunoglobulin, which is used in Canada (and elsewhere)
to treat several immune, blood and neurological disorders, is made from plasma
imported from American for-profit plasma centers.8
Evidence about the degree of social support (or disapproval) for morally
controversial activities is scant. Even less evidence is available regarding whether
the social support is general or country specific; for example, whether the moral

3. See Alvin E. Roth, Repugnance as a Constraint on Markets, 21 J. ECON. PERSP. 37, 38 (2007).
4. Id. at 39.
5. Gay Marriage Around the World, PEW RES. CTR. (Aug. 8, 2017), http://www.pewforum.org/
2017/08/08/gay-marriage-around-the-world-2013/ [https://perma.cc/2VRD-9D3S].
6. See Kimberly D. Krawiec, Altruism and Intermediation in the Market for Babies, 66 WASH. &
LEE L. REV. 203, 225 (2009) (“Some states, either through statute or court decisions, take approaches
relatively friendly to commercial surrogacy arrangements, for example, by analyzing the parties’ intent
at the time of the contract.”).
7. Assisted Human Reproduction Act, S.C. 2004, c. 2 (Can.).
8. Our Commitment to Increasing Plasma Sufficiency in Canada, CAN. BLOOD SERV.,
https://blood.ca/en/blood/plasma-sufficiency [https://perma.cc/CZ7C-YZZX] (last visited Mar. 1, 2018).
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opposition that a society may have toward a certain trade refers only to allowing
that trade in that same country, or everywhere. In particular, individuals may
display some form of “moral NIMBY-ism”; that is, they may wish to reap the
benefits from a contested transaction (compensated plasma donation) while
outsourcing the moral costs of it. Thus, with specific reference to the case of
plasma donations in Canada, this article asks the following questions:
• How prevalent is the opposition to compensating plasma donors in
Canada?
• What are the main reasons for and against payments? What is the
relative importance of moral concerns, of concerns regarding safety,
and of considerations about the importance of guaranteeing a
sufficient supply to cover medical needs?
• Are Canadians opposed to paying all plasma donors, or just Canadian
plasma donors?
• Do the majority of Canadians exhibit “consequentialist” preferences
(that is, considerations about the practical impacts of allowing
payments are important to their attitudes toward payments), or
“deontological” preferences (meaning their opposition to
compensating plasma donors reflects a “sacred” value that cannot be
sacrificed)?
We conducted a randomized survey experiment with a representative sample
of 826 Canadian residents. In the survey, respondents were randomly assigned to
express their opinion in favor or against compensating plasma donors in one of
three countries: Canada, the United States, or Australia. Similar to Canada,
compensation to plasma donors is not allowed in Australia, and Australia also
relies on imported plasma to satisfy its domestic needs.9 Next, according to
whether the subjects were in favor of or against paying plasma donors, we asked
how much the respondents agreed with a set of possible motivations for their
position. The sentences that expressed these motivations stressed the morality of
allowing or not allowing payments, the risk of attracting donors with
transmittable diseases if payments were legal, and the importance (or lack
thereof) of guaranteeing a sufficient domestic supply. By asking a representative
sample from one country about support for payments in their own country or
elsewhere, we can determine whether attitudes are general or specific to a
person’s country of residence. The additional questions about the individuals’
motives behind their stances further help to identify not only the differential
relevance of these motives, but also the weight assigned to them when referring
to one’s own country as opposed to other countries.
Part II provides details on plasma uses and collection in Canada, Australia,
and the United States. Part III describes our experimental design. Part IV

9. Robert Slonim, Carmen Wang & Ellen Garbarino, The Market for Blood, 28 J. ECON. PERSP.
177, 185 (2014).
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presents our results, and Part V draws conclusions.
II
INSTITUTIONAL DETAILS
A. Plasma Uses And Plasma Donation
Plasma is the liquid part of blood that remains after removing red blood cells,
white blood cells, platelets, and other cellular components.10 It consists of water,
salts, enzymes, antibodies and other proteins (such as albumin, fibrinogen, and
globulins), and it performs several functions, including clotting blood and fighting
infections.
Plasma is used for direct transfusion. It is also used in the production
of therapies to treat people with chronic diseases and disorders such as primary
immunodeficiency, hemophilia and genetic lung disease, and in the treatment of
trauma, burns and shock. Source plasma is plasma that is collected from healthy,
voluntary donors through a process called plasmapheresis and is used for further
manufacturing into final therapies (a process called fractionation).11 Recovered
plasma is collected through whole blood donation in which plasma is separated
from its cellular components. Recovered plasma may also be used for
fractionation. Producing all of these therapies requires a large number of plasma
donations. For example, the annual treatment of one single patient with
hemophilia requires 1,200 plasma donations.12
During a source plasma donation, blood is drawn from one arm and
channeled through an automated machine that collects the plasma and returns
the remaining blood components (white blood cells, red blood cells, and
platelets) to the donor. It typically takes between one and three hours to donate
source plasma.
Stringent regulations are in place for the screening and testing of plasma
donors. Moreover, the manufacturing process for plasma products includes
multiple, mandatory steps that remove or inactivate any contaminants, including
viruses that could be present. These viral inactivation steps have proven to be
effective at eliminating new pathogens such as West Nile Virus, which has been
transmitted by blood transfusion but never by use of plasma products. More
generally, over the last few decades, plasma product manufacturing technology
has evolved, and many of the identified risks from the past have been mitigated
or eliminated.13
10. What is Plasma?, DONATING PLASMA, http://www.donatingplasma.org/donation/what-isplasma [https://perma.cc/UGR9-SER6] (last visited Feb. 18, 2018).
11. Slonim et al., supra note 9, at 183.
12. GRIFOLS, PLASMA: A SOURCE OF LIFE, https://www.grifolsplasma.com/en/web/plasma/aboutplasma-donation/plasma-a-source-of-life [https://perma.cc/S6EL-8ZGP] (last visited Feb. 18, 2018).
13. Plasma Donation in Canada, GOV’T CAN. (Jan. 5, 2018), https://www.canada.ca/en/healthcanada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/factsheets/plasma-donation-canada.html [https://perma.cc/29SX-J4LH].
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B. Plasma Collection in Canada, Australia, and the United States
Compensation for plasma donors—specifically, for the supply of plasma to be
used for fractionation—and the establishment of for-profit plasma centers are
legal activities in several countries, such as the United States, Czech Republic,
and Austria. Many other countries prohibit payments.14 A common feature of
most countries that ban compensation is that they run a deficit of plasma for
domestic uses; therefore, they rely on imports, most often of plasma collected in
countries where compensation is legal because, typically, these countries have a
surplus of available plasma.15 The different legal status of payments to donors
around the world and the international plasma procurement and allocation
patterns are somewhat exemplary of the challenges in defining repugnant trades
and in determining the reasons for bans to compensation.
In Canada, most provinces prohibit compensation to plasma donors. Ontario
and Alberta passed legislation that prohibits compensation for plasma in 2014
and 2017, respectively.16 In Quebec, payments to plasma donors have been illegal
since 1994,17 and currently, British Columbia and Nova Scotia are considering
similar legislation.18 Private plasma centers that pay donors are active in
Saskatchewan though.19 However, there is a debate about banning compensation
for plasma donors at the federal level.20
Canadian Blood Services and Héma-Québec are the only organizations that
collect plasma (and blood) for transfusion, and they do so exclusively from
unpaid donors.21 Plasma collected from volunteers in Canada is sufficient for
14. Slonim et al., supra note 9, at 185.
15. See Blood Safety and Availability—Fact Sheet, WORLD HEALTH ORG. (June 2017),
http://www.who.int/mediacentre/factsheets/fs279/en/ [https://perma.cc/2SB5-J3PY]. See generally
PLASMA FRACTIONATION REVIEW COMMITTEE, COMMONWEALTH OF AUSTRALIA, REVIEW OF
AUSTRALIA’S PLASMA FRACTIONATION ARRANGEMENTS 69–83 (2006),
https://www.health.gov.au/internet/main/publishing.nsf/Content/B3B4E1D741764DD2CA257BF000193
A6F/$File/plasma_FINAL%20as%20at%2030%20November%202006.pdf
[https://perma.cc/4Z7H9VWW] (describing several countries’ processes for acquiring the necessary amount of plasma).
16. Voluntary Blood Donations Act, S.A. 2017, V–5 (Can.); Voluntary Blood Donations Act, S.O.
2014, c. 14 (Can.).
17. Civil Code of Québec, CQLR c CCQ-1991 art. 25 (Can.).
18. See Debates and Proceedings on Bill No. 37, Voluntary Blood Donations Act Before the House
of Assembly of Nova Scotia, 1064–1080 (2017) (Can.) (debating the merits of the proposed bill, the
Voluntary Blood Donations Act); Kelly Grant, Blood Agency Seeking $855-Million in Funding to Boost
Plasma Supply, Document Reveals, GLOBE & MAIL (Aug. 14, 2017), https://beta.theglobeandmail.com/
news/national/blood-agency-seeking-855-million-in-funding-to-boost-plasma-supply-documentreveals/article35980339/?ref=http://www.theglobeandmail.com& [https://perma.cc/MJ8H-F4AS].
19. See Canadian Plasma Clinic That Pays Donors $25 per Visit Opens in Saskatoon, CBC NEWS
(Feb. 19, 2016), http://www.cbc.ca/news/canada/saskatoon/plasma-clinic-opens-saskatoon-1.3453062
[https://perma.cc/E322-PAMU].
20. The Canadian Press, NDP: Plasma Clinics That Pay Donors Should Be Banned by Federal
Government, HUFFINGTON POST (Jan. 15, 2016), http://www.huffingtonpost.ca/2016/01/15/ndp-wantsfederal-ban-on-plasma-clinics-that-pay-donors-but-saskatchewan-oks-it_n_8992022.html
[https://perma.cc/LJ7R-6T3H].
21. See CANADIAN BLOOD SERVICES, HÉMA-QUÉBEC, https://blood.ca/en/news-tags/hema-
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transfusions across the country. However, the domestic supply of plasma for the
production of therapies and pharmaceutical products is not sufficient to meet the
domestic demand. Imported plasma products make up for the difference.22
In Australia, Australian Red Cross Blood Service (ARCBS) is the only
organization that collects plasma (and blood) for transfusion and fractionation,
and they do so exclusively from unpaid donors because payments to donors are
not allowed. The biopharmaceutical company CSL Limited fractionates plasma
from ARCBS donations and supplies a range of immunoglobulin, hyper-immune
products, clotting factors and albumin, for domestic use. Similar to Canada,
plasma collected from Australian volunteers is sufficient for blood transfusions
in the country. However, the domestic supply of plasma for the production of
therapies and pharmaceutical products is not sufficient to meet the domestic
demand, so Australia must import plasma products to fulfill the medical needs of
its patient population.23
In contrast, plasma donors in the United States receive compensation.
Individuals can donate a maximum of two times within a seven-day period,24
receiving about $30 per donation.25 In the United States, the supply of plasma is
sufficient to meet the domestic demand;26 moreover, the United States exports
plasma to other countries, including Canada and Australia.27 For
example, approximately 83% of immunoglobulin used in Canada is made from
American paid plasma donors.28 Similarly, Australia imports 43% of its
immunoglobulin from outside of Australia.29
III
EXPERIMENTAL DESIGN
We conducted a survey experiment with a sample of 826 Canadian
quebec [https://perma.cc/5GSN-WF7A] (last visited Feb. 18, 2018).
22. Backgrounder Paper—Plasma Donations in Canada, GOV’T CAN. (June 27, 2013),
https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvementconsultations/biologics-radiopharmaceuticals-genetic-therapies/backgrounder-paper-plasma-donationscanada.html [https://perma.cc/45BJ-J3BB].
23. See NAT’L BLOOD AUTHORITY AUSTL., ANNUAL REPORT 2015–16 39 (2016) (explaining the
National Blood Authority’s contracts with plasma suppliers to complement domestic supply when
domestic plasma production cannot meet demand).
24. 21 C.F.R. § 640.65 (2017).
25. See, e.g., Alexa Valiente, Mark Abdelmalek & Lauren Pearle, Why Thousands of Low-Income
Americans “Donate” Their Blood Plasma to For-Profit Centers, ABC NEWS (Jan. 13, 2017),
http://abcnews.go.com/US/thousands-low-income-americans-donate-blood-plasma-profit/story?
id=44710257 [https://perma.cc/J9UZ-7ASF].
26. Slonim, et al., supra note 9, at 185.
27. See Gilbert M. Gaul, The Blood Brokers—America: The OPEC of the Global Plasma
Industry, PHILA. INQUIRER (Sep. 28, 1989), http://www.bloodbook.com/part-5.html [https://perma.cc/
9AMG-L83M] (“More than half the estimated 12 million liters of plasma used in medicines worldwide
comes from the United States.”).
28. CANADIAN BLOOD SERVICES, supra note 8.
29. NAT’L BLOOD AUTHORITY AUSTL., supra note 23, at 33.
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respondents recruited by ResearchNow, a market research data company. The
recruitment protocol was such that the sample would be representative of the
Canadian population for such features as gender, age, and geographical location.
Figure 1 outlines the flow of the survey. All participants first read a text of
about 320 words that included general information about plasma and plasma
donation: what plasma is, what its medical uses are, the different ways of
collecting plasma from donors, some basic features of the process of plasma
fractionation and the manufacturing of plasma products, and some information
on the quantity of plasma needed to address certain diseases.
The survey then introduced a random-experimental component with a 2-by2 design. With ex-ante 50% probability, we assigned respondents to one of two
texts. The first text provided a description of the plasma procurement and
allocation system in Canada—we refer to this group as the “Canada text” group.
The text explained that the majority of Canadian provinces, including the largest
ones, prohibit compensation to donors as well as the establishment of for-profit
plasma centers. It also included a summary of the different positions in the debate
about legalizing compensation. Proponents of compensating plasma donors
argue that payments would increase supply, and that there have been no
instances of contaminated plasma from paid donors in the past twenty years.
Among the arguments against payments were the concerns that compensation
may hamper the voluntary system, attract donors with communicable diseases,
and violate human dignity because certain transactions should be kept out of the
market. Finally, the text noted that about 83% of plasma for fractionation used
in Canada is imported from the United States, where payments to plasma donors
are legal.
The remaining respondents read a similar text with information about plasma
procurement and allocation in Australia, another country that does not allow
payments to donors (we refer to this group as the “Australia text” group). The
information provided was specific to the Australian case, but the structure of the
text, including information about imports from countries that allow payments
(for example, the United States), was the same as the text about Canada.
We then further divided the participants in each of the two groups into two
subgroups, again with ex-ante 50% probability for each respondent. Within the
“Canada text” group, we asked one subgroup to express their opinion about
whether payments to plasma donors should be allowed in Canada (we refer to
this subgroup as the “Canada text & Canada vote” group). We asked the other
subgroup whether payments to plasma donors should be allowed in the United
States—the “Canada text & US vote” group. Similarly, for the “Australia text”
group, we asked one subgroup to express their opinion about whether payments
to plasma donors should be allowed in Australia (the “Australia text & Australia
vote” group), and we asked the other subgroup whether payments to plasma
donors should be allowed in the United States (“Australia text & US vote”
group). The respondents could check one of two options: “I think payments to
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plasma donors should be allowed in Canada/Australia/the United States,” or “I
think payments to plasma donors should not be allowed in Canada/Australia/the
United States.”
Because all respondents were Canadian residents, this design allowed us to
assess both the support for compensation to plasma donors in their own country
and the support for payments in other countries. We chose Australia as one of
these other countries because, in addition to having cultural similarities and a
level of economic development comparable to Canada’s, compensation to plasma
donors is illegal in Australia, and it imports plasma for fractionation just like
Canada. We also included the United States because compensation is legal in the
United States and the country runs a vast supply surplus that allows for exports
of plasma. Canada relies on this imported plasma. to produce a range of
therapies. We could therefore determine whether any support or opposition to
compensation was general or specific to the country of residence of the
population of interest (Canadians), and whether the current legal framework in
a country correlated with the level of agreement or aversion toward
compensation.
After the participants answered about their support for compensating plasma
donors, the survey directed them to different sets of questions, according to
whether they expressed opposition or favor, and according to the country on
which they expressed their view. These questions contained statements that
reported a set of reasons for being in favor of or against payments. For each of
the listed reasons, we asked the respondents to give a rating from 0 to 100 to
indicate how important that reason was in motivating their position.
For the “Canada text & Canada vote” and the “Australia text & Australia
vote” groups, we proposed the following three reasons to those who opposed
payments to plasma donors:
• “It is immoral to provide monetary payments to plasma donors in
Canada/Australia— donations should be unpaid”
• “Monetary payments may attract donors who carry transmittable
diseases”
• “Increasing domestic supply of plasma is not a priority,
Canada/Australia can rely on imports”
For those who did not support payments in the United States (respondents in
the “Canada text & US vote” or “Australia text & US vote” groups), we replaced
the third statement above, which is not applicable to the United States because
the United States does not rely on imports, with the following:
• “The US produces more plasma than their domestic needs, so paying
plasma donors is unnecessary”
For the respondents in the “Canada text & Canada vote” and the “Australia
text & Australia vote” groups who expressed favor towards payments to plasma
donors, we presented the following reasons, again asking the respondents to rate
them from 0 to 100 depending on how important each statement was in
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motivating them to be in favor of payments:
• “It is morally appropriate to provide monetary payments to plasma
donors in Canada/Australia—they incur costs in terms of time spent
donating and physical discomfort to supply a valuable resource”
• “Monetary payments to plasma donors would increase the availability
of domestic plasma and reduce Canada’s/Australia’s dependence on
other countries”
• “Plasma donors receive monetary payments in some other countries,
such as the United States, therefore they should be paid also in
Canada/Australia”
Finally, we provided a list of five reasons to participants in the “Canada text
& US vote” and “Australia text & US vote” groups who favored compensating
plasma donors:
• “It is morally appropriate to provide monetary payments to plasma
donors in the United States—they incur costs in terms of time spent
donating and physical discomfort to supply a valuable resource”
• “Monetary payments to plasma donors increase the availability of
domestic plasma and ensure that the US does not depend on other
countries”
• “Some countries, such as Canada/Australia, rely on imported plasma
from paid donors in the US”
• “Plasma donors receive monetary payments in some other countries,
therefore they should be paid also in the United States”
• “It is currently legal to pay plasma donors in the US, so things should
stay as they are”
We chose these motives to encompass some of the main arguments that recur
frequently in the debate about the legalization of compensation in Canada and
elsewhere: moral considerations, concerns about the safety of plasma donated by
paid donors, and the effects of compensation on domestic supply. Because
payments are already legal in the United States, we modified the statements
accordingly, and also added some statements that were specific to the U.S. case.
We then proposed an additional question only to the respondents who had
expressed opposition to payments in the form of a hypothetical scenario.
Participants expressed their favor or opposition to the following statement: “If
there was a shortage of plasma (i.e., the domestic supply plus the imports were
not sufficient to satisfy [Canada’s/Australia’s/the US’] need for plasma), then I
would consider supporting the introduction of monetary payments to plasma
donors in Canada/Australia/the US.” The reason for having this additional
question was to collect more evidence on the underlying motives for opposing
payments; a disagreement with the hypothetical statement above would indicate
a strong form of opposition, one that reflects deontological preferences and thus
is not amenable, for example, to making trade-offs between different values or
objectives. Conversely, an agreement with the statements would indicate that
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although the respondent currently opposes payments to plasma donors, her
preferences are more consequentialist, which implies that she is willing to make
trade-offs between moral arguments and supply considerations.
The last part of the survey, common to all respondents, included a series of
socio-demographic questions. We asked participants to report their age, gender,
ethnicity, religious beliefs, household income, education level, marital status, job
market status, geographical area of residence within Canada, whether they had
children, their views about social and economic issues, and whether they had
volunteered or donated to charity in the previous two years.
Figure 1: Experimental design flow.

IV
DATA AND RESULTS
A. Sample and Balance Checks
Table 1 reports some summary features of the 826 respondents. Consistent
with our design, the sample is reasonably representative of the distributions by
gender, age, ethnicity, geographic region, religious attitude, education, work
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status, family status, income, and political orientation of the Canadian
population. To check whether the sample was well-balanced across the four
experimental conditions, we estimated a multinomial logit regression of the four
treatment conditions on indicators for various socio-demographic features; we
found that the participants’ characteristics are unrelated to the treatment to
which the participants were assigned (p > chi2 = 0.957).
Table 1: Descriptive statistics.
This table reports the distribution of the socio-demographic characteristics of
the 826 survey respondents.
N. of respondents

826

Women

52.2%

College degree

50.4%

Age 18-34
Age 35-54
Age 55+

27.8%
38.5%
33.7%

Employed
Retired

53.9%
21.2%

Caucasian/White
East Asian
Other

74.2%
9.3%
16.5%

Married
With children
Income > $50K

53.1%
53.1%
69.2%

Atlantic
Ontario
Quebec
West

7.4%
37.9%
22.0%
32.8%

Liberal on social issues
Conservative on social issues
Liberal on economic issues
Conservative on economic issues

43.5%
18.1%
33.7%
23.4%

Atheist
Christan
Jewish
Muslim
Other

25.6%
54.9%
3.0%
13.8%
2.7%

Volunteer/donates to charity

74.3%

B. Results
1. Result 1: The vast majority of respondents support the legalization of
payments for plasma donors.
Figure 2 reports the attitudes of the respondents toward legalizing payments
for plasma donors. Each column represents the share of participants who
expressed support for legal payments in each of the four experimental conditions.
The main finding is that the large majority of respondents are in favor of
legalizing payments to plasma donors. We estimate that 72.6% of Canadians are
in favor of compensating plasma donors in Canada (95% c.i. 66.4%–78.8%),
78.7% (95% c.i. 73.5%–84%) are in favor of compensating plasma donors in
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Australia, and 76.4% (95% c.i. 72.1%–80.6%) are in favor of paying donors in
the United States (combining the data from respondents who were given
information about the demand and supply of plasma in Canada and those who
were given information about Australia). The first-order implication of these
results is that a representative sample of Canadians widely supports payments to
plasma donors. The differences in support rates for different countries are
relatively small and only marginally statistically significant when comparing
Canada and Australia (one-tailed t test: p=0.07, two-tailed t test: p=0.14). The
stronger support for payments in the U.S. may suggest that respondents display
some form of “NIMBY-ism” whereby people enjoy the benefit of a given
transaction but do not want to carry the ethical costs of it. The higher support for
payments in Australia may suggest some moral relativism, meaning individuals
might be more in favor of allowing morally contentious activities if they occur
farther away. However, the small differences described above suggest that these
mechanisms play only a minor role, if any at all.
2. Figure 2: Support for compensation to plasma donors.
The figure reports the percentage of respondents in each condition who
expressed support for legalizing compensation for plasma donors. Error bars
represent 95% confidence intervals (±1.96 * s.e.).

Table 2 reports estimates from Ordinary Least Squares regression models
where the outcome variable is a binary indicator for support for plasma donor
payments. Estimates in the first column are from a model that included only the
indicators for the treatment conditions (as such, these estimates coincide with the
statistics reported in Figure 1). The estimates in the second column are from a
model that includes controls for the individual characteristics listed in Table 1.
Consistent with the random assignment (and the balance of the sample as
discussed above), the inclusion of these additional controls did not meaningfully
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change the estimates of the coefficients on the treatment indicators. Moreover,
none of the estimates of the parameters on the indicators for the various
individual characteristics is statistically significant at the 5% level or less. This
implies that the support rates for compensating plasma donors are very similar
across the main socio-demographic categories of the Canadian population.
3. Table 2: Support for payments to plasma donors—regression analysis.
This table reports estimates from Ordinary Least Squares regressions. The
dependent variable is equal to one if the respondent expressed support for
plasma donor payments and zero otherwise. The main explanatory variables of
interest are indicators for the experimental conditions. Column (2) also includes
control variables. The omitted treatment indicator (represented by the constant
in column (1)) is “Canada text & Canada vote”; the omitted age category is Age
55+; the omitted region category is Atlantic; the omitted religion is Jewish.
Standard errors are in parentheses (** p<0.01, * p<0.05, + p<0.1).

Outcome variable:

Supports payments

Explanatory variables:

(1)

(2)

Canada text & US vote

0.029
(0.045)
0.061
(0.041)
-0.044
(0.060)

0.035
(0.045)
0.062
(0.042)
-0.053
(0.061)
0.044
(0.054)
-0.017
(0.047)
-0.051
(0.031)
-0.108+
(0.065)
-0.012
(0.043)

Australia text & Australia vote
Australia text & US vote
Age 18-34
Age 18-54
Woman
East Asian
White

(continues on next page)
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(continued from previous page)
Ontario

0.726**
(0.032)

-0.041
(0.060)
-0.057
(0.062)
-0.010
(0.059)
-0.037
(0.036)
0.042
(0.036)
-0.069
(0.084)
-0.051
(0.080)
-0.163+
(0.091)
-0.191
(0.126)
0.033
(0.033)
0.015
(0.039)
-0.046
(0.058)
-0.053
(0.036)
0.027
(0.043)
-0.017
(0.056)
0.002
(0.044)
0.012
(0.050)
0.030
(0.035)
0.855**
(0.130)

826
0.003
-0.000744

824
0.032
0.000817

Quebec
West
Married
With children
Atheist/agnostic
Christian
Muslim
Other
College degree
Employed
Retired
Income > $50K
Liberal on social issues
Conservative on social issues
Liberal on economic issues
Conservative on economic issues
Volunteer/donates to charity
Constant

Observations
R-squared
Adjusted R-squared

4. Result 2: Respondents who oppose compensation for plasma donors are
mainly concerned about moral issues and the safety of plasma coming from paid
donors.
Figure 3 shows cumulative distribution functions of the ratings assigned by
respondents who opposed paying plasma donors to the set of motives described
in the previous section. For each line, a given point (x on the horizontal axis, y on
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the vertical axis) indicates the share y of respondents who rated a particular
motive x or less. Among respondents who expressed opposition to payments in
Australia and Canada, there was a similar distribution of relevance given to
morality and safety concerns. The average ratings for the concerns about morality
and safety were, respectively, 69.2 and 68.4 for Canada, and 72.6 and 68.9 for
Australia. As mentioned above, organizations and authorities that source plasma
from countries where donors receive compensation consider the imported
plasma to be as safe as the plasma obtained domestically. However, our results
indicate a widespread perception among Canadians that paid plasma poses a
health threat. At the individual level and especially for those who expressed
opposition about paying donors in Canada, there is a strong positive correlation
between the concerns for morality and safety (correlation coefficient = 0.54,
significant at the 5% level). Conversely, the possibility for a country to rely on
imported plasma was a much less important reason for the respondents’
opposition to allowing payments in that country. The average rating was 35.6
among respondents opposed to paid donors in Canada, and 46.4 among those
opposed to paid donors in Australia (two-sided p-value for difference in means
= 0.06; p-value from Kolmogorov-Smirnov test for differences in distributions =
0.053). A possible interpretation of this difference is that Canadians might be
reluctant to reveal that they oppose payments to domestic plasma donors because
they know that their country can rely on imported plasma from the United States,
whereas they might be more likely to reveal this belief when referring to another
country. The respondents who were against compensating donors in the United
States rated concerns for morality and safety of the collected plasma very
similarly to respondents who opposed payments in Canada and Australia. The
ratings for these concerns were also similar to the ratings for a third motive that
we proposed to these respondents, namely that payments are not needed because
the country already runs a supply surplus.
5. Figure 3: Ratings of reasons against compensation.
The graphs below report cumulative distribution functions of the ratings
(between 0 and 100) that respondents opposed to legalizing compensation to
plasma donors gave to three reasons: “It is immoral to provide monetary
payments to plasma donors in Canada/Australia/United States—donations
should be unpaid” (labeled “Immoral” in the graphs); “Monetary payments may
attract donors who carry transmittable diseases” (labeled “Diseases”);
“Increasing the domestic supply of plasma is not a priority, Canada/Australia can
rely on imports” (labeled “Can rely on imports”); and, “The US produces more
plasma than their domestic needs, so paying plasma donors is unnecessary”
(labeled “No need, supply is plentiful”).
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Canada text & Canada vote

Australia text & Australia vote

Canada text & US vote

Australia text & US vote

6. Result 3: Respondents who are in favor of payments to plasma donors place
great importance on guaranteeing a robust domestic supply of plasma.
Figure 4 presents cumulative distribution functions of the ratings assigned by
respondents who favored paying plasma donors to the set of motives described
in the previous section. The three motives (labeled “Moral,” “Domestic supply,”
and “Paid elsewhere” in the graphs) all received high ratings and were strongly
correlated at the individual respondent level. Securing a higher domestic supply
was significantly more important than the other reasons, suggesting that
respondents who are in favor of paying plasma donors might be characterized as
having more consequentialist (outcome-oriented) views. The respondents who
expressed support for the paid-donor system in the United States gave similar
ratings to all of the motives they were asked to consider. Again, the importance
of guaranteeing a sufficient domestic supply was the reason that received the
highest ratings.
7. Figure 4: Rating of reasons for compensation.
The graphs below report cumulative distribution functions of the ratings
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(between 0 and 100) that respondents in favor of compensation to plasma donors
gave to the following reasons: “It is morally appropriate to provide monetary
payments to plasma donors in Canada (Australia, the United [S]tates)—they
incur costs in terms of time spent donating and physical discomfort to supply a
valuable resource” (labeled “Moral” in the graphs); “Monetary payments to
plasma donors would increase the availability of domestic plasma and reduce
Canada’s/Australia’s dependence on other countries,” or, for the United States,
“Monetary payments to plasma donors increase the availability of domestic
plasma and ensure that the US does not depend on other countries” (labeled
“Domestic supply”); “Plasma donors receive monetary payments in some other
countries, therefore they should be paid also in Canada/Australia/the United
States” (labeled “Paid elsewhere”); “Some countries, such as Canada/Australia,
rely on imported plasma from paid donors in the US” (labeled “Other countries
rely on US imports”); and, “It is currently legal to pay plasma donors in the US,
so things should stay as they are” (labeled “Status quo”).
Canada text & Canada vote

Australia text & Australia vote

Canada text & US vote

Australia text & US vote
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8. Result 4: About half of the respondents who opposed payments would
reconsider their position in the case of a supply shortage.
As shown in Figure 5, between 43.5% (Canada or Australia text & US vote)
and 51% (Australia text & Australia vote) of the participants who opposed
payments reported that they would be willing to support compensating plasma
donors in the case of a supply shortage, that is, if the domestic supply plus imports
were insufficient to meet domestic demand. The differences between the
treatment groups, however, are not statistically significant both because the
differences are not large and because of the relatively small sample sizes of the
four groups. These positions were similar across the various socio-demographic
characteristics of our respondents, as shown by the regression estimates in Table
3.
9. Figure 5: Percentage of respondents against plasma donor compensation
who would reconsider their position in the case of a supply shortage.
The figure reports the shares of respondents who indicated opposition to legal
compensation for plasma donors, but who responded that they would consider
supporting payments in the case of a supply shortage. Error bars represent 95%
confidence intervals (±1.96 * s.e.).

10. Table 3: Support for payments in case of supply shortage—regression
analysis.
This table reports the estimates from an Ordinary Least Squares regression. The
dependent variable is equal to one if the respondent answered, “Yes I would be in favor
of paying plasma donors in case of a supply shortage”—that is, if the domestic supply plus
imports were insufficient to meet the domestic needs. The main explanatory variables of
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interest are indicators for the experimental conditions. Column (2) also includes control
variables. The omitted treatment indicator (represented by the constant in column (1)) is
“Canada text & Canada vote”; the omitted age category is Age 55+; the omitted region
category is Quebec; the omitted religion is Other. Standard errors are in parentheses (**
p<0.01, * p<0.05, + p<0.1).

Outcome variable: Support if shortage
Explanatory variables:
Canada text & US vote
Australia text & Australia vote
Australia text & US vote
Age 18-34
Age 18-54
Woman
East Asian
White
Atlantic
Ontario
West
(continues on next page)

-0.105
(0.106)
0.024
(0.099)
0.008
(0.145)
0.240+
(0.125)
0.078
(0.111)
-0.084
(0.080)
-0.124
(0.143)
-0.106
(0.113)
0.183
(0.171)
0.005
(0.098)
0.099
(0.102)
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Married
With children
Atheist/agnostic
Christian
Jewish
Muslim
College degree
Employed
Retired
Income > $50K
Liberal on social issues
Conservative on social issues
Liberal on economic issues
Conservative on economic issues
Volunteer/donates to charity
Constant

Observations
R-squared
Adjusted R-squared

-0.159+
(0.085)
0.028
(0.090)
-0.060
(0.215)
-0.121
(0.212)
-0.213
(0.329)
0.064
(0.219)
0.011
(0.081)
-0.082
(0.099)
0.030
(0.138)
-0.024
(0.090)
0.053
(0.123)
-0.272+
(0.155)
0.074
(0.126)
0.275+
(0.142)
0.275**
(0.085)
0.438+
(0.256)
195
0.175
0.0475
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As a further attempt to study whether those who were willing to reconsider
their opposition to payments held different views and values towards
compensation, we compared the ratings they attributed to the various reasons
proposed (Figure 6). Overall, and both for respondents who opposed payments
in Canada and in Australia, those who would not support compensation, even in
case of plasma supply shortage, gave higher importance to moral and safety
concerns.
11. Figure 6: Ratings of reasons for being against payments and whether
respondents would reconsider their position in case of supply shortage.
The graphs below report cumulative distribution functions of the ratings that
respondents who were against compensating plasma donors gave to the three
motives the survey asked them to rate (between 0 and 100), separately for those
who would support payments in case of supply shortage and those who would
still oppose payments even in case of a shortage. “Immoral” stands for the survey
statement: “It is immoral to provide monetary payments to plasma donors in
Canada/Australia/United States—donations should be unpaid.” “Diseases”
stands for: “Monetary payments may attract donors who carry transmittable
diseases.” “Can rely on imports” (only for Canada and Australia) stands for:
“Increasing domestic supply of plasma is not a priority, Canada/Australia can rely
on imports.”
Immoral (N=190)

Diseases (N=187)

Can rely on imports (N=100)
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V
CONCLUSION
The first-order finding from our study is that the vast majority of respondents
expressed support for compensation to plasma donors. We found no evidence of
widespread societal opposition to payments to plasma donors. Although the
support of our Canadian respondents was higher for paying plasma donors in
Australia and the United States than in Canada, the differences were small,
suggesting a weak role for “moral NIMBY-ism” or moral relativism in explaining
the findings. Moreover, there were no differences across the different categories
of respondents—for example, by gender, religious attitude, geographical
location, age, education, or political orientation. This suggests that attitudes
towards payments to plasma donors reflect deep-seated individual traits that
observable socio-demographics are unable to predict and that go beyond, for
example, gender differences or left–right political preference divides.
Second, moral concerns were the highest-rated reason that respondents gave
for being against payments. Respondents also gave high importance to concerns
for the safety of plasma supplied by compensated donors, although most of the
plasma in Canada does come from compensated American donors. Furthermore,
the organizations in charge of the procurement and allocation of plasma have
repeatedly assured (and proven) that plasma from American paid donors is as
safe as plasma from Canadian unpaid donors. Because safety concerns are
unjustified by the evidence, appropriate informational campaigns could help
dispel this misconception. More opportunistic considerations, such as the fact
that the supply surplus from the United States allows Canada to rely on imports
without the need to pay donors domestically, had a much less important role as
motivation for opposing compensation.
In contrast, among those in favor of legalizing compensation for donors (in
Canada as well as in Australia), the highest-rated motive was to guarantee a
higher domestic supply. The majority of the respondents who were in favor of
legalizing compensation also agreed that compensation would not run against
mainstream Canadian moral and societal values. Most Canadians, therefore,
seem to espouse a consequentialist view to issues related to the procurement of
plasma.
Because roughly half of those who declared to be against payments reported
that they would reconsider their position if the domestic supply and imports were
insufficient to meet domestic demand, we may conclude that up to about 85% of
our Canadian respondents share a consequentialist view regarding the regulation
of the demand and supply of plasma. Conversely, the remaining approximately
15% of respondents who continued to oppose payment even when faced with a
hypothetical supply shortage can be characterized by deontological preferences:
prohibiting payments is a value of a higher order than guaranteeing an adequate
supply of plasma. The finding that the attitudes of Canadians toward
compensating plasma donors are very similar regardless of whether donors are in
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Canada or elsewhere is consistent with the attitudes reported in the survey and
the stated motivations, representing general moral values of the respondents.
In addition to advancing our understanding of individuals’ attitudes and social
support for morally contentious transactions, our study contributes to the current
debate in Canada and elsewhere about whether payments to plasma donors
should be legal. The growing demand for plasma, especially for the manufacture
of therapeutic products, creates an urgent need for a careful discussion on the
relative merits of different procurement and allocation systems in a way that
addresses the increasing demand while abiding by the prevailing moral values in
a society. We hope that the evidence from this study will provide insights to
address these questions of relevance for public health.
More generally, we see our study as supporting a broader philosophy about
the role of research in informing societal debates and choices. Many political
decisions are thorny because, for example, they involve conflicts between
competing societal and moral values and interests that policymakers are called to
resolve. Examples include legislation about gestational surrogacy; physicianassisted death; same-sex unions; the donation of organs, blood, plasma and
gametes; prostitution; and the treatment of animals in farms, among others.
Other political questions, ranging from redistribution policies to the treatment of
migrants and refugees, also touch upon rooted beliefs and customs of individuals
and societies. In these and similar cases, our view is that a primary role for
empirical social scientists is to devise rigorous methodologies to elicit the actual
beliefs of the population of interest. Because the choices to be considered often
concern activities that are not legal or policies still to be implemented, surveys of
individual opinions are often based on hypothetical scenarios and, as such,
require some care in interpreting the results. Notwithstanding this caveat, with
proper methodological approaches it is possible to provide reliable evidence
about the prevailing opinions on complex, morally-charged topics. Of course, in
a representative democracy, it is a prerogative of policymakers to not follow the
prevailing positions of a population. However, we believe that reliable evidence
of these opinions should be, whenever available, considered in the political
decision process.

